tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
US Market
IPHYF
Innate Pharma SA
RESEARCH TOOLSreports

Innate Pharma SA (IPHYF) Cash flow

27 Followers

Innate Pharma SA Cash Flow

IPHYF's free cash flow for Q4 2025 was €-21.67M. For the 2025 fiscal year, IPHYF's free cash flow was decreased by €-45.61M and operating cash flow was €-21.59M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
€ -52.76M€ -6.90M€ -32.56M€ -19.15M€ -58.46M
Investing Cash Flow
€ 7.29M€ 9.20M€ 20.63M€ 1.88M€ -917.00K
Financing Cash Flow
€ 6.07M€ -6.01M€ -1.97M€ -1.83M€ 26.82M
End Cash Position
€ 28.09M€ 66.40M€ 70.61M€ 84.22M€ 103.76M
Free Cash Flow
€ -52.90M€ -7.29M€ -34.91M€ -20.28M€ -59.79M
Currency in EUR

Innate Pharma SA Cash Flow